Literature DB >> 12410207

Cardiolipin deficiency in X-linked cardioskeletal myopathy and neutropenia (Barth syndrome, MIM 302060): a study in cultured skin fibroblasts.

Fredoen Valianpour1, Ronald J A Wanders, Henk Overmars, Peter Vreken, Albert H Van Gennip, Frank Baas, Barbara Plecko, Rene Santer, Kolja Becker, Peter G Barth.   

Abstract

We determined cardiolipin concentrations in cultured skin fibroblasts of 5 patients with X-linked cardioskeletal myopathy and neutropenia (Barth syndrome, MIM 302060) and in two groups of control patients. High-performance liquid chromatography-electrospray mass spectrometry was used to quantify total cardiolipin and subclasses of cardiolipin molecular species in cultured skin fibroblasts. Total cardiolipin and cardiolipin subclasses were decreased in patients with Barth syndrome as compared with normal control patients and disease control patients. Patients with Barth syndrome have a specific decrease of various cardiolipin molecular species, foremost tetralineoyl-cardiolipin. Therefore the analysis of cardiolipin in fibroblasts offers a specific biochemical approach to detect this disorder.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12410207     DOI: 10.1067/mpd.2002.129174

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  35 in total

Review 1.  Advances in analytical mass spectrometry to improve screening for inherited metabolic diseases.

Authors:  Wulf Röschinger; Bernhard Olgemöller; Ralph Fingerhut; Bernhard Liebl; Adelbert A Roscher
Journal:  Eur J Pediatr       Date:  2003-11-14       Impact factor: 3.183

Review 2.  Delineating the role of alterations in lipid metabolism to the pathogenesis of inherited skeletal and cardiac muscle disorders: Thematic Review Series: Genetics of Human Lipid Diseases.

Authors:  Harjot K Saini-Chohan; Ryan W Mitchell; Frédéric M Vaz; Teresa Zelinski; Grant M Hatch
Journal:  J Lipid Res       Date:  2011-11-07       Impact factor: 5.922

3.  Direct MALDI-MS analysis of cardiolipin from rat organs sections.

Authors:  Hay-Yan J Wang; Shelley N Jackson; Amina S Woods
Journal:  J Am Soc Mass Spectrom       Date:  2006-12-06       Impact factor: 3.109

4.  Shotgun lipidomics of cardiolipin molecular species in lipid extracts of biological samples.

Authors:  Xianlin Han; Kui Yang; Jingyue Yang; Hua Cheng; Richard W Gross
Journal:  J Lipid Res       Date:  2006-01-31       Impact factor: 5.922

Review 5.  Cardiolipin synthesis for the assembly of bacterial and mitochondrial membranes.

Authors:  Michael Schlame
Journal:  J Lipid Res       Date:  2007-12-12       Impact factor: 5.922

Review 6.  Multisystem manifestations of mitochondrial disorders.

Authors:  Stefano Di Donato
Journal:  J Neurol       Date:  2009-03-01       Impact factor: 4.849

7.  Cardiolipin Regulates Mitophagy through the Protein Kinase C Pathway.

Authors:  Zheni Shen; Yiran Li; Alexander N Gasparski; Hagai Abeliovich; Miriam L Greenberg
Journal:  J Biol Chem       Date:  2017-01-05       Impact factor: 5.157

8.  Mitochondrial dysfunction and reduced prostaglandin synthesis in skeletal muscle of Group VIB Ca2+-independent phospholipase A2gamma-deficient mice.

Authors:  Emiko Yoda; Keiko Hachisu; Yoshitaka Taketomi; Kotomi Yoshida; Masanori Nakamura; Kazutaka Ikeda; Ryo Taguchi; Yoshihito Nakatani; Hiroshi Kuwata; Makoto Murakami; Ichiro Kudo; Shuntaro Hara
Journal:  J Lipid Res       Date:  2010-07-12       Impact factor: 5.922

9.  Overexpression of branched-chain amino acid aminotransferases rescues the growth defects of cells lacking the Barth syndrome-related gene TAZ1.

Authors:  Diana Antunes; Arpita Chowdhury; Abhishek Aich; Sreedivya Saladi; Nofar Harpaz; Mark Stahl; Maya Schuldiner; Johannes M Herrmann; Peter Rehling; Doron Rapaport
Journal:  J Mol Med (Berl)       Date:  2019-01-03       Impact factor: 4.599

Review 10.  Mitochondrial disorders.

Authors:  Massimo Zeviani; Antonella Spinazzola
Journal:  Curr Neurol Neurosci Rep       Date:  2003-09       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.